Download Files:
Atosiban
SKU
HY-17572-10 mg
Category Peptides
Tags Endocrinology; Cancer, GPCR/G Protein, Oxytocin Receptor;Vasopressin Receptor
$92 – $290
Products Details
Product Description
– Atosiban (RW22164; RWJ22164) is a nonapeptide competitive vasopressin/oxytocin receptor antagonist, and is a desamino-oxytocin analogue. Atosiban is the main tocolytic agent and has the potential for spontaneous preterm labor research[1].
Web ID
– HY-17572
Storage Temperature
– -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Shipping
– Blue Ice
Applications
– Cancer-programmed cell death
Molecular Formula
– C43H67N11O12S2
Citations
– Front Neurosci. 2021 Sep 10;15:723064.|J Pharm Biomed Anal. 2022: 115156.|J Pharm Biomed Anal. 11 December 2021, 114518.
References
– [1]Philip J Ryan, et al. Oxytocin-receptor-expressing Neurons in the Parabrachial Nucleus Regulate Fluid Intake. Nat Neurosci. 2017 Dec;20(12):1722-1733.|[2]Sanu O, et al. Critical appraisal and clinical utility of atosiban in the management of preterm labor.
Ther Clin Risk Manag. 2010 Apr 26;6:191-9.
CAS Number
– 90779-69-4
Molecular Weight
– 994.19
Compound Purity
– 99.09
SMILES
– O=C([C@H](CSSCCC(N[C@@H](C1=O)CC2=CC=C(OCC)C=C2)=O)NC([C@@H](NC(C(NC([C@](N1)([H])[C@@H](C)CC)=O)[C@H](O)C)=O)CC(N)=O)=O)N(CCC3)[C@@H]3C(N[C@@H](CCCN)C(NCC(N)=O)=O)=O
Clinical Information
– Launched
Research Area
– Endocrinology; Cancer
Solubility
– DMSO : ≥ 16.67 mg/mL|H2O : 16.67 mg/mL (ultrasonic)
Target
– Oxytocin Receptor;Vasopressin Receptor
Pathway
– GPCR/G Protein
Product type
– Peptides
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.